Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

NET 1Gastrointestinal 1Endocrine 1

Conditions

Carcinoma, Hepatocellular 44Liver Neoplasms 18Colorectal Neoplasms 15Neoplasm Metastasis 11Cholangiocarcinoma 11Pancreatic Neoplasms 9Colonic Neoplasms 9Barrett Esophagus 7Rectal Neoplasms 6Recurrence 5Esophageal Neoplasms 4Biliary Tract Neoplasms 3Bile Duct Neoplasms 3Hepatitis B 2Gallbladder Neoplasms 2Stomach Neoplasms 1Solid Tumor Including Thyroid, Bone, Liver, Pancreas 1Pancreatic cancer, adult 1Pancreatic Neuroendocrine Tumors, WHO Grade I-II 1Neuroendocrine Tumors 1Neoplastic Cells, Circulating 1Neoplasms, Glandular and Epithelial 1Neoplasms 1Neoplasm Micrometastasis 1Multi-organ Metastatic Colorectal Cancer 1Liver Metastasis Colon Cancer 1Klatskin Tumor 1Jaundice, Obstructive 1Hypertension, Portal 1Hepatitis B, Chronic 1

Interventions

Everolimus 7lutetium Lu 177 dotatate 4lanreotide 4Sunitinib 4Temozolomide 3Octreotide 3Nivolumab 3Magnetic Resonance Spectroscopy 3Fluorodeoxyglucose F18 3Capecitabine 3177Lu-octreotide, DOTA(0)-Tyr(3)- 3copper dotatate CU-64 2amino-acid, glucose, and electrolyte solution 2Quality of Life 2FAPI-46 2veliparib 1tivozanib 1tislelizumab 1telotristat ethyl 1surufatinib 1romidepsin 1repotrectinib 1pralsetinib 1pembrolizumab 1pasireotide 1gallium Ga 68 dotatate 1gadoteridol 1gadoterate meglumine 1gadolinium ethoxybenzyl DTPA 1gadodiamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroendocrine Tumors × Radiofrequency Ablation × Gastrointestinal × Clear all
NCT02973204 2021-04-28

Circulating Tumor Cells and Tumor DNA in HCC and NET

University of Aarhus

Completed
167 enrolled
EndocrineGastrointestinalNET

Carcinoma, Hepatocellular, Neoplastic Cells, Circulating, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡